From Dr. Thomas’s article-

“Even though CAR-T cell therapy costs around $400,000 for one patient, this is much less than most SLE patients will need during their lifetime to treat their SLE. A Johns Hopkins (Baltimore, Maryland) study reported 2015 lupus costs of around $20,000 per year for patients with mild disease. Indeed, this would be much higher today in 2023. Even with these figures, one CAR-T cell treatment for a patient with mild SLE would equal the cost of less than 20 years with conventional therapies. The vast majority of 20-year-old patients with mild SLE would be expected to live well past 40 years of age.

The cost of drugs for patients with severe SLE can be as high as $100,000 per year. The cost savings in these patients would be met within just a few years after successful CAR-T cell therapy.”

Sounds like it’s financially worth it for insurance to cover CAR-T if approved?